2021-2027 Global and Regional Joint Pain Injections Industry Status and Prospects Professional Market Research Report Standard Version
Date: Aug-2021 | Id: MACRC-71306 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Joint Pain Injections market was valued at 2778.41 Million USD in 2020 and will grow with a CAGR of 4.97% from 2020 to 2027, based on Mnemonics Rresearch newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. By Market Verdors: Allergan Pfizer Sanofi Anika Therapeutics Ferring Bioventus Flexion Therapeutics Zimmer Biomet Holdings SEIKAGAKU CORPORATION Chugai Pharmaceutical By Types: Corticosteroid Injections Hyaluronic Acid Injections By Applications: Hospital Pharmacies Retail Pharmacies Online Pharmacies Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the globalmarket and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Joint Pain Injections Market Size Analysis from 2022 to 2027 1.5.1 Global Joint Pain Injections Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Joint Pain Injections Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Joint Pain Injections Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Joint Pain Injections Industry Impact Chapter 2 Global Joint Pain Injections Competition by Types, Applications, and Top Regions and Countries 2.1 Global Joint Pain Injections (Volume and Value) by Type 2.1.1 Global Joint Pain Injections Consumption and Market Share by Type (2016-2021) 2.1.2 Global Joint Pain Injections Revenue and Market Share by Type (2016-2021) 2.2 Global Joint Pain Injections (Volume and Value) by Application 2.2.1 Global Joint Pain Injections Consumption and Market Share by Application (2016-2021) 2.2.2 Global Joint Pain Injections Revenue and Market Share by Application (2016-2021) 2.3 Global Joint Pain Injections (Volume and Value) by Regions 2.3.1 Global Joint Pain Injections Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Joint Pain Injections Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Joint Pain Injections Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Joint Pain Injections Consumption by Regions (2016-2021) 4.2 North America Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) 4.10 South America Joint Pain Injections Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Joint Pain Injections Market Analysis 5.1 North America Joint Pain Injections Consumption and Value Analysis 5.1.1 North America Joint Pain Injections Market Under COVID-19 5.2 North America Joint Pain Injections Consumption Volume by Types 5.3 North America Joint Pain Injections Consumption Structure by Application 5.4 North America Joint Pain Injections Consumption by Top Countries 5.4.1 United States Joint Pain Injections Consumption Volume from 2016 to 2021 5.4.2 Canada Joint Pain Injections Consumption Volume from 2016 to 2021 5.4.3 Mexico Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 6 East Asia Joint Pain Injections Market Analysis 6.1 East Asia Joint Pain Injections Consumption and Value Analysis 6.1.1 East Asia Joint Pain Injections Market Under COVID-19 6.2 East Asia Joint Pain Injections Consumption Volume by Types 6.3 East Asia Joint Pain Injections Consumption Structure by Application 6.4 East Asia Joint Pain Injections Consumption by Top Countries 6.4.1 China Joint Pain Injections Consumption Volume from 2016 to 2021 6.4.2 Japan Joint Pain Injections Consumption Volume from 2016 to 2021 6.4.3 South Korea Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 7 Europe Joint Pain Injections Market Analysis 7.1 Europe Joint Pain Injections Consumption and Value Analysis 7.1.1 Europe Joint Pain Injections Market Under COVID-19 7.2 Europe Joint Pain Injections Consumption Volume by Types 7.3 Europe Joint Pain Injections Consumption Structure by Application 7.4 Europe Joint Pain Injections Consumption by Top Countries 7.4.1 Germany Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.2 UK Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.3 France Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.4 Italy Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.5 Russia Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.6 Spain Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.7 Netherlands Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.8 Switzerland Joint Pain Injections Consumption Volume from 2016 to 2021 7.4.9 Poland Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 8 South Asia Joint Pain Injections Market Analysis 8.1 South Asia Joint Pain Injections Consumption and Value Analysis 8.1.1 South Asia Joint Pain Injections Market Under COVID-19 8.2 South Asia Joint Pain Injections Consumption Volume by Types 8.3 South Asia Joint Pain Injections Consumption Structure by Application 8.4 South Asia Joint Pain Injections Consumption by Top Countries 8.4.1 India Joint Pain Injections Consumption Volume from 2016 to 2021 8.4.2 Pakistan Joint Pain Injections Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Joint Pain Injections Market Analysis 9.1 Southeast Asia Joint Pain Injections Consumption and Value Analysis 9.1.1 Southeast Asia Joint Pain Injections Market Under COVID-19 9.2 Southeast Asia Joint Pain Injections Consumption Volume by Types 9.3 Southeast Asia Joint Pain Injections Consumption Structure by Application 9.4 Southeast Asia Joint Pain Injections Consumption by Top Countries 9.4.1 Indonesia Joint Pain Injections Consumption Volume from 2016 to 2021 9.4.2 Thailand Joint Pain Injections Consumption Volume from 2016 to 2021 9.4.3 Singapore Joint Pain Injections Consumption Volume from 2016 to 2021 9.4.4 Malaysia Joint Pain Injections Consumption Volume from 2016 to 2021 9.4.5 Philippines Joint Pain Injections Consumption Volume from 2016 to 2021 9.4.6 Vietnam Joint Pain Injections Consumption Volume from 2016 to 2021 9.4.7 Myanmar Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 10 Middle East Joint Pain Injections Market Analysis 10.1 Middle East Joint Pain Injections Consumption and Value Analysis 10.1.1 Middle East Joint Pain Injections Market Under COVID-19 10.2 Middle East Joint Pain Injections Consumption Volume by Types 10.3 Middle East Joint Pain Injections Consumption Structure by Application 10.4 Middle East Joint Pain Injections Consumption by Top Countries 10.4.1 Turkey Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.3 Iran Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.5 Israel Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.6 Iraq Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.7 Qatar Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.8 Kuwait Joint Pain Injections Consumption Volume from 2016 to 2021 10.4.9 Oman Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 11 Africa Joint Pain Injections Market Analysis 11.1 Africa Joint Pain Injections Consumption and Value Analysis 11.1.1 Africa Joint Pain Injections Market Under COVID-19 11.2 Africa Joint Pain Injections Consumption Volume by Types 11.3 Africa Joint Pain Injections Consumption Structure by Application 11.4 Africa Joint Pain Injections Consumption by Top Countries 11.4.1 Nigeria Joint Pain Injections Consumption Volume from 2016 to 2021 11.4.2 South Africa Joint Pain Injections Consumption Volume from 2016 to 2021 11.4.3 Egypt Joint Pain Injections Consumption Volume from 2016 to 2021 11.4.4 Algeria Joint Pain Injections Consumption Volume from 2016 to 2021 11.4.5 Morocco Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 12 Oceania Joint Pain Injections Market Analysis 12.1 Oceania Joint Pain Injections Consumption and Value Analysis 12.2 Oceania Joint Pain Injections Consumption Volume by Types 12.3 Oceania Joint Pain Injections Consumption Structure by Application 12.4 Oceania Joint Pain Injections Consumption by Top Countries 12.4.1 Australia Joint Pain Injections Consumption Volume from 2016 to 2021 12.4.2 New Zealand Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 13 South America Joint Pain Injections Market Analysis 13.1 South America Joint Pain Injections Consumption and Value Analysis 13.1.1 South America Joint Pain Injections Market Under COVID-19 13.2 South America Joint Pain Injections Consumption Volume by Types 13.3 South America Joint Pain Injections Consumption Structure by Application 13.4 South America Joint Pain Injections Consumption Volume by Major Countries 13.4.1 Brazil Joint Pain Injections Consumption Volume from 2016 to 2021 13.4.2 Argentina Joint Pain Injections Consumption Volume from 2016 to 2021 13.4.3 Columbia Joint Pain Injections Consumption Volume from 2016 to 2021 13.4.4 Chile Joint Pain Injections Consumption Volume from 2016 to 2021 13.4.5 Venezuela Joint Pain Injections Consumption Volume from 2016 to 2021 13.4.6 Peru Joint Pain Injections Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Joint Pain Injections Consumption Volume from 2016 to 2021 13.4.8 Ecuador Joint Pain Injections Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Joint Pain Injections Business 14.1 Allergan 14.1.1 Allergan Company Profile 14.1.2 Allergan Joint Pain Injections Product Specification 14.1.3 Allergan Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Pfizer 14.2.1 Pfizer Company Profile 14.2.2 Pfizer Joint Pain Injections Product Specification 14.2.3 Pfizer Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Sanofi 14.3.1 Sanofi Company Profile 14.3.2 Sanofi Joint Pain Injections Product Specification 14.3.3 Sanofi Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Anika Therapeutics 14.4.1 Anika Therapeutics Company Profile 14.4.2 Anika Therapeutics Joint Pain Injections Product Specification 14.4.3 Anika Therapeutics Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 Ferring 14.5.1 Ferring Company Profile 14.5.2 Ferring Joint Pain Injections Product Specification 14.5.3 Ferring Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Bioventus 14.6.1 Bioventus Company Profile 14.6.2 Bioventus Joint Pain Injections Product Specification 14.6.3 Bioventus Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 Flexion Therapeutics 14.7.1 Flexion Therapeutics Company Profile 14.7.2 Flexion Therapeutics Joint Pain Injections Product Specification 14.7.3 Flexion Therapeutics Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Zimmer Biomet Holdings 14.8.1 Zimmer Biomet Holdings Company Profile 14.8.2 Zimmer Biomet Holdings Joint Pain Injections Product Specification 14.8.3 Zimmer Biomet Holdings Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 SEIKAGAKU CORPORATION 14.9.1 SEIKAGAKU CORPORATION Company Profile 14.9.2 SEIKAGAKU CORPORATION Joint Pain Injections Product Specification 14.9.3 SEIKAGAKU CORPORATION Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.10 Chugai Pharmaceutical 14.10.1 Chugai Pharmaceutical Company Profile 14.10.2 Chugai Pharmaceutical Joint Pain Injections Product Specification 14.10.3 Chugai Pharmaceutical Joint Pain Injections Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Joint Pain Injections Market Forecast (2022-2027) 15.1 Global Joint Pain Injections Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Joint Pain Injections Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Joint Pain Injections Value and Growth Rate Forecast (2022-2027) 15.2 Global Joint Pain Injections Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Joint Pain Injections Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Joint Pain Injections Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Joint Pain Injections Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Joint Pain Injections Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Joint Pain Injections Consumption Forecast by Type (2022-2027) 15.3.2 Global Joint Pain Injections Revenue Forecast by Type (2022-2027) 15.3.3 Global Joint Pain Injections Price Forecast by Type (2022-2027) 15.4 Global Joint Pain Injections Consumption Volume Forecast by Application (2022-2027) 15.5 Joint Pain Injections Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology